Navigation Links
Amgen's Third Quarter 2013 Revenues Increased 10 Percent To $4.7 Billion And Adjusted Earnings Per Share (EPS) Increased 16 Percent To $1.94
Date:10/22/2013

ched reconciliations.The Company also noted significant progress on key strategic priorities:

  • The acquisition of Onyx Pharmaceuticals closed on Oct. 1, 2013. Kyprolis sales grew 6 percent sequentially in the third quarter to $65 million.
  • Amgen advanced its efforts to develop a presence in cardiovascular disease by acquiring U.S. commercial rights to ivabradine, an innovative product already approved in over 100 countries for heart failure and angina.
  • In Japan, the Amgen-Astellas strategic alliance began operations on Oct. 1, 2013, and will develop and launch five Phase 3 molecules, starting with evolocumab (AMG 145).
  • In China, the joint venture with Betta Pharma Co. Ltd. to commercialize Vectibix® (panitumumab) also began operations, and Amgen announced a R&D partnership with ShanghaiTech University.
  • In emerging growth markets, Amgen repurchased rights to Neulasta and NEUPOGEN from Roche. Effective Jan. 1, 2014, Amgen will assume responsibility for these products in markets outside the U.S. and Europe with annual sales of approximately $200 million.
  • Product Sales Performance

  • Total product sales increased 11 percent driven by strong year-over-year performance from NEUPOGEN, Neulasta, ENBREL, Prolia and XGEVA.
  • Combined Neulasta and NEUPOGEN sales increased 18 percent year-over-year.
  • Global Neulasta sales increased 9 percent driven mainly by price.
  • Global NEUPOGEN sales increased 50 percent including a $155 million order from the U.S. government.
  • Enbrelsales increased 7 percent year-over-year driven mainly by price.
  • Aranesp® (darbepoetin alfa) sales decreased 10 percent year-over-year.
  • EPOGEN® (epoetin alfa) sales were flat year-over-year.
  • Sensipar®/Mimpara® (cinacalcet) sales increased 7 percent year-over-year driven by increases in uni
    '/>"/>

  • SOURCE Amgen
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

    Related medicine technology :

    1. Perrigo Company Will Release Third Quarter Fiscal 2012 Results On May 8, 2012
    2. PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results
    3. Pro-Dex, Inc. Announces Fiscal 2012 Third Quarter Financial Results Conference Call and Webcast
    4. Techne Corporation Releases Unaudited Third Quarter and Nine Month Fiscal Year 2012 Results
    5. Cardica Announces Fiscal 2012 Third Quarter Financial Results
    6. Hill-Rom Announces Third Quarter 2012 Dividend
    7. Cardinal Health Reports Third-Quarter Results
    8. TPI to Host Third Quarter of Fiscal Year 2012 Earnings Conference Call on Tuesday, May 15, 2012 at 9:00 a.m. ET
    9. Pro-Dex, Inc. Announces Fiscal Third Quarter and Nine Month Results
    10. ThermoGenesis Corp. To Announce Third Quarter Fiscal 2012 Results On May 10, 2012
    11. Perrigo Reports Record Third Quarter Revenue And Earnings And Raises Full Year EPS Guidance
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/4/2015)... and VANCOUVER, British Columbia ... OGXI ) announced today that it will report ... 14, 2015. Company management will host a conference call ... provide an overview of financial results, clinical development programs ... access the webcast, log on to the Investor Relations ...
    (Date:5/4/2015)... , May 4, 2015  BioSpecifics Technologies Corp. ... in class collagenase-based products marketed as XIAFLEX ® ... XIAPEX ®  in the EU, will announce its first ... U.S. financial markets on Monday, May 11, 2015 and ... a.m. ET the next day, Tuesday May 12, 2015.  ...
    (Date:5/4/2015)... N.J. , May 4, 2015 PTC Therapeutics, ... and reported financial results for the first quarter ending March ... strong start this year. In our first full quarter since ... to Translarna, the first treatment for nonsense mutation Duchene Muscular ... double the number on treatment since our last earnings call," ...
    Breaking Medicine Technology:BioSpecifics Technologies Corp. to Report First Quarter 2015 Financial Results on Monday, May 11, 2015 2PTC Therapeutics Reports First Quarter 2015 Financial Results and Provides Corporate Update 2PTC Therapeutics Reports First Quarter 2015 Financial Results and Provides Corporate Update 3PTC Therapeutics Reports First Quarter 2015 Financial Results and Provides Corporate Update 4PTC Therapeutics Reports First Quarter 2015 Financial Results and Provides Corporate Update 5PTC Therapeutics Reports First Quarter 2015 Financial Results and Provides Corporate Update 6PTC Therapeutics Reports First Quarter 2015 Financial Results and Provides Corporate Update 7PTC Therapeutics Reports First Quarter 2015 Financial Results and Provides Corporate Update 8PTC Therapeutics Reports First Quarter 2015 Financial Results and Provides Corporate Update 9
    ... YORK , June 22, 2011 The Alzheimer,s ... awarded a grant to Axxam SpA to develop small ... (Logo: http://photos.prnewswire.com/prnh/20090805/DC57332LOGO ) The ... compounds that block the puringeric receptor, P2X7, which is ...
    ... (NYSE: AGN ) today announced a new ... Obesity and Related Diseases that found the cost ... Allergan,s LAP-BAND® Adjustable Gastric Banding System, was offset by ... surgery eligible patients with diabetes, and within four years ...
    Cached Medicine Technology:Alzheimer's Drug Discovery Foundation Supports Axxam To Develop Novel Therapeutics for Alzheimer's Disease 2New Study Finds That Gastric Banding Pays for Itself In Approximately Two Years for Patients With Diabetes and Four Years for Patients Without Diabetes 2New Study Finds That Gastric Banding Pays for Itself In Approximately Two Years for Patients With Diabetes and Four Years for Patients Without Diabetes 3New Study Finds That Gastric Banding Pays for Itself In Approximately Two Years for Patients With Diabetes and Four Years for Patients Without Diabetes 4New Study Finds That Gastric Banding Pays for Itself In Approximately Two Years for Patients With Diabetes and Four Years for Patients Without Diabetes 5New Study Finds That Gastric Banding Pays for Itself In Approximately Two Years for Patients With Diabetes and Four Years for Patients Without Diabetes 6
    (Date:5/5/2015)... San Rafael, CA (PRWEB) May 05, 2015 ... Snader in 2012, with the belief that ultimate Frisbee™ ... can be the next sport that engages the world. ... the youth level, by creating opportunities for young athletes ... makes this collaboration with MLU the perfect fit. , ...
    (Date:5/5/2015)... (PRWEB) May 05, 2015 NovaSom, Inc., ... upcoming episode of Innovations with Ed Begley Jr., airing ... times TBA. , This segment will focus on NovaSom, ... Viewers will learn about their AccuSom® home sleep test, ... that provides continuous patient support and next-day test results ...
    (Date:5/5/2015)... (PRWEB) May 05, 2015 Every year, news ... seasons. Turns out, the worst dry eye season is spring, ... spikes in most of the United States. The only season ... water advocate Sharon Kleyne, host of the Sharon Kleyne Hour™ ... on her radio show of May 11, 2015. Kleyne is ...
    (Date:5/5/2015)... (PRWEB) May 05, 2015 McMunn ... and end-to-end automation solutions, announced today that it has ... and corporate identity. According to president and founder, Larry ... aligned with the company’s strategy for growth and expansion ... successful for the past 30 years by building close, ...
    (Date:5/5/2015)... BioFit Engineered Products , a globally ... from its two latest lines at NeoCon 2015, June ... Headlining the company’s exhibit will be new Pro and ... well as the unveiling of the fifth model of ... Metzger will deliver in-booth presentations each day of the ...
    Breaking Medicine News(10 mins):Health News:US Sports Camps, Nike Ultimate Camps, and Major League Ultimate Host Youth Ultimate Summer Camps in Philidelphia 2Health News:Innovations with Ed Begley, Jr. to Explore NovaSom, Inc., in Upcoming Episode 2Health News:Nature’s Tears EyeMist tear film supplement soothes dry eye caused by spring pollen season, reports inventor Sharon Kleyne 2Health News:Nature’s Tears EyeMist tear film supplement soothes dry eye caused by spring pollen season, reports inventor Sharon Kleyne 3Health News:McMunn Associates Launches New Corporate Branding with New Website 2Health News:BioFit to Introduce New Models from Latest Specialized Ergonomic Seating Lines at NeoCon 2015 2Health News:BioFit to Introduce New Models from Latest Specialized Ergonomic Seating Lines at NeoCon 2015 3
    ... D. Eilers Professor of Medicine and Health Care Management and ... the Wharton School, was presented with the Alpha Omega Alpha ... of Medical Colleges (AAMC). The award was presented on ... Recognizing Dr. Asch, the AAMC said, "Dr. ...
    ... don,t help those with existing disease , TUESDAY, Nov. ... from a young age might prevent early signs of ... study in mice. , Recent research suggests that the ... in the development of Alzheimer,s. In the new study, ...
    ... ... Dr Cheryl Effron of Cosmetic Dermatology of Orange County offers Sculptra Aesthetic@ at affordable ... (PRWEB) ... of Cosmetic Dermatology of Orange County offers Sculptra Aesthetic@ at affordable prices., , , ...
    ... ... to have policyholders select and pay extra for either a plan which covers abortion or ... ... over abortion coverage and the possibility that the same thing could happen again in the ...
    ... ... a North American company, is expanding its cutting edge vibration exercise technology into South ... the Pro Elite, Air Reflex and Contour Plus, are now available in South America. ... (Vocus) November ...
    ... ATLANTA Emory University Rollins School of Public Health ... topics at the American Public Health Association,s annual meeting ... national recommendations that a physician screen chest pain patients ... Department (ED). Additional public health research findings from ...
    Cached Medicine News:Health News:David A. Asch, M.D., M.B.A., receives AAMC Distinguished Teacher Award 2Health News:FDA-Approved Sculptra@ Now Offers by Orange County Dermatologist Dr. Cheryl Effron 2Health News:“Think Outside the Box” Blog Proposes Better Abortion Compromise for Health Reform 2Health News:WAVE's Revolutionary Whole-Body Advanced Vibration Exercise Is Now Available in South America 2Health News:Some chest pain patients wait longer than 10 minutes to see ER physician 2
    ... 2000 Pipette is a synonym for pipetting ... robust design, and superior operating comfort. Its ... the measuring stroke and blow-out as well ... system ensures utmost accuracy and precision. Ejection ...
    Inquire...
    ... The Eppendorf Reference Series 2000 Pipette ... smooth stroke, a compact and robust design, ... button is used to operate the measuring ... the tip. Product features:Eppendorf "pipette/tip" system ensures ...
    ... The Eppendorf Reference Series 2000 Pipette is ... stroke, a compact and robust design, and ... is used to operate the measuring stroke ... tip. Product features:Eppendorf "pipette/tip" system ensures utmost ...
    Medicine Products: